QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Artelo Biosciences
(NASDAQ:ARTL)
0.331
0.0005[0.15%]
At close: May 16
0.33
-0.0010[-0.30%]
After Hours: 9:26AM EDT
15 minutes delayed
Day High/Low0.31 - 0.35
52 Week High/Low0.3 - 1.33
Open / Close0.33 / -
Float / Outstanding41.9M / 42.3M
Vol / Avg.231.6K / 1.5M
Mkt Cap14M
P/E-
50d Avg. Price0.41
Div / Yield-
Payout Ratio-
EPS-0.08
Total Float41.9M

Artelo Biosciences (NASDAQ:ARTL), Quotes and News Summary

Artelo Biosciences (NASDAQ: ARTL)

Day High/Low0.31 - 0.35
52 Week High/Low0.3 - 1.33
Open / Close0.33 / -
Float / Outstanding41.9M / 42.3M
Vol / Avg.231.6K / 1.5M
Mkt Cap14M
P/E-
50d Avg. Price0.41
Div / Yield-
Payout Ratio-
EPS-0.08
Total Float41.9M
Benzinga - 4 days ago
Benzinga - Apr 13, 2022, 10:49AM
Benzinga - Apr 13, 2022, 10:11AM
Benzinga - Apr 13, 2022, 8:30AM
Benzinga - Mar 28, 2022, 9:25AM
Benzinga - Mar 21, 2022, 8:33AM
Benzinga - Jan 12, 2022, 8:36AM
Benzinga - Jan 11, 2022, 8:34AM
Benzinga - Nov 29, 2021, 8:35AM
Benzinga - Nov 2, 2021, 11:21AM
Benzinga - Nov 1, 2021, 12:29PM
Benzinga - Nov 1, 2021, 6:30AM
Benzinga - Sponsored
load more
Sector: Health Care.Industry: Pharmaceuticals
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-11
REV
Q2 2022Est.ActualSurprise
EPS-0.070-0.050 0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Artelo Biosciences Questions & Answers

Q
How do I buy Artelo Biosciences (ARTL) stock?
A

You can purchase shares of Artelo Biosciences (NASDAQ: ARTL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Artelo Biosciences's (ARTL) competitors?
Q
What is the target price for Artelo Biosciences (ARTL) stock?
A

The latest price target for Artelo Biosciences (NASDAQ: ARTL) was reported by HC Wainwright & Co. on Monday, November 1, 2021. The analyst firm set a price target for 4.00 expecting ARTL to rise to within 12 months (a possible 1108.46% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Artelo Biosciences (ARTL)?
A

The stock price for Artelo Biosciences (NASDAQ: ARTL) is $0.331 last updated Today at May 16, 2022, 7:45 PM UTC.

Q
Does Artelo Biosciences (ARTL) pay a dividend?
A

There are no upcoming dividends for Artelo Biosciences.

Q
When is Artelo Biosciences (NASDAQ:ARTL) reporting earnings?
A

Artelo Biosciences’s Q3 earnings are confirmed for Monday, July 11, 2022.

Q
Is Artelo Biosciences (ARTL) going to split?
A

There is no upcoming split for Artelo Biosciences.

Q
What sector and industry does Artelo Biosciences (ARTL) operate in?
A

Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.